Risky Business: Cardiac Prevention, Stratification, and Novel Non-Invasive Diagnostics (2025)

Learning Objectives:

  • Improve discussions on lifestyle changes and comorbid management for primary prevention of atherosclerotic cardiovascular disease (ASCVD)
  • Understand risk stratification testing for prediction of ASCVD and secondary prevention treatments.
  • Increase awareness of novel testing for ASCVC utilizing non-invasive imaging.

Marcel Letourneau, DO (he/him/his)

Interventional Cardiology

Corewell Health West

Interventional Cardiology, Corwell Health West Heart and Vascular Center. 

VTE Director Holland Hospital.

Key:

Complete
Failed
Available
Locked
Pre-Test
5 Questions  |  1 attempt  |  0/5 points to pass
5 Questions  |  1 attempt  |  0/5 points to pass
Webcast
04/24/2025 at 10:30 AM (EDT)  |  Recorded On: 04/24/2025  |  30 minutes
04/24/2025 at 10:30 AM (EDT)  |  Recorded On: 04/24/2025  |  30 minutes
Post-Test
5 Questions  |  Unlimited attempts  |  4/5 points to pass
5 Questions  |  Unlimited attempts  |  4/5 points to pass
Evaluation
17 Questions